Patents by Inventor Po-Shiuan HSIEH

Po-Shiuan HSIEH has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11786530
    Abstract: Disclosed herein is a method against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The method includes administering to a subject in need thereof a first active ingredient selected from the group consisting of methotrexate (MIX) and a pharmaceutically acceptable salt thereof, and a second active ingredient selected from the group consisting of remdesivir and a pharmaceutically acceptable salt thereof. A molar ratio of the first active ingredient to the second active ingredient ranges from 1:13 to 1:25.
    Type: Grant
    Filed: March 9, 2022
    Date of Patent: October 17, 2023
    Assignee: NATIONAL YANG MING CHIAO TUNG UNIVERSITY
    Inventors: Jinn-Moon Yang, Po-Shiuan Hsieh, Chih-Heng Huang, Yu-Hsiu Chang, Nikhil Pathak, Yen-Chao Hsu, Yun-Ti Chen, Nung-Yu Hsu
  • Publication number: 20220288080
    Abstract: Disclosed herein is a method against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The method includes administering to a subject in need thereof a first active ingredient selected from the group consisting of methotrexate (MIX) and a pharmaceutically acceptable salt thereof, and a second active ingredient selected from the group consisting of remdesivir and a pharmaceutically acceptable salt thereof. A molar ratio of the first active ingredient to the second active ingredient ranges from 1:13 to 1:25.
    Type: Application
    Filed: March 9, 2022
    Publication date: September 15, 2022
    Inventors: Jinn-Moon YANG, Po-Shiuan HSIEH, Chih-Heng HUANG, Yu-Hsiu CHANG, Nikhil PATHAK, Yen-Chao HSU, Yun-Ti CHEN, Nung-Yu HSU
  • Publication number: 20220088002
    Abstract: Disclosed herein is a method against coronavirus infection, which includes administering to a subject in need thereof an effective amount of 6-bromo-2-[1-(2,5-dimethylphenyl)-5-methyl-1H-pyrazol-4-yl]-quinoline-4-carboxylic acid or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: May 28, 2021
    Publication date: March 24, 2022
    Inventors: Jim-Tong HORNG, Wen-Fang TANG, Hui-Ping TSAI, Chung-Fan HSIEH, Chia-Yi LIN, Guan-Hua LIN, Yu-Li CHEN, Po-Shiuan HSIEH, Tien-Yao CHANG, Yu-Hsiu CHANG
  • Publication number: 20220088105
    Abstract: Disclosed herein is a method against coronavirus infection, which includes administering to a subject in need thereof a composition containing a water-extracted product of Perilla frutescens.
    Type: Application
    Filed: March 30, 2021
    Publication date: March 24, 2022
    Inventors: Jim-Tong Horng, Wen-Fang Tang, Hui-Ping Tsai, Tien-Yao Chang, Po-Shiuan Hsieh, Yu-Hsiu Chang, Chung-Fan Hsieh, Chia-Yi Lin, Guan-Hua Lin, Yu-Li Chen
  • Publication number: 20220089691
    Abstract: The present invention relates to anti-SARS-CoV-2 antibodies and/or antigen-binding fragments thereof, which are useful for specific detection of SARS-CoV-2 in a biological sample. The present invention also provides methods and kits for detecting SARS-CoV-2 and methods and compositions for use in diagnosis and treatment of coronavirus disease (COVID-19) using the anti-SARS-CoV-2 antibodies as described herein.
    Type: Application
    Filed: September 15, 2020
    Publication date: March 24, 2022
    Inventors: Szu-Chia LAI, Yu-Yine Huang, Yi-Ling Chen, Jiunn-Jye Wey, Po-Shiuan Hsieh, Meng-Hung Tsai, Jyh-Hwa Kau
  • Publication number: 20220087974
    Abstract: Disclosed herein is a method against coronavirus infection, which includes administering to a subject in need thereof an effective amount of 8-benzoyl-4-methyl-9-phenyl-furo[2,3-h]chromen-2-one or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: May 28, 2021
    Publication date: March 24, 2022
    Inventors: Jim-Tong HORNG, Wen-Fang TANG, Hui-Ping TSAI, Chung-Fan HSIEH, Chia-Yi LIN, Guan-Hua LIN, Yu-Li CHEN, Po-Shiuan HSIEH, Tien-Yao CHANG, Yu-Hsiu CHANG